Described herein are pharmaceutical packaging units which avert oxidative degradation of morphine, hydromorphone, promethazine as well as other oxygen-sensitive drugs, these types of methods including a syringe using an oxygen permeable idea cap, a hermetically sealed oxygen barrier blister packaging with extremely minimal permeability to oxygen an